EN AR

Pharmaceutical

Ferriprox® (deferiprone)

Ferriprox® treats iron overload in patients with thalassaemia major when deferoxamine therapy is contraindicated or inadequate. It is FDA and EMA approved. The product has been commercially available since 1999 and is currently distributed to over 60 countries worldwide. AlwanMed is the exclusive KSA distributor of this medication.

 

Direct Purchase and Public Sector Procurements

AlwanMed offers best in class sourcing solutions from our extensive global network of suppliers.

Jars